https://www.selleckchem.com/pr....oducts/nvp-bgt226.ht
Transcatheter patent ductus arteriosus (PDA) closure has become the first‑choice method of treatment in the majority of patients. However, device selection poses a challenge. This study aimed to analyze periprocedural and 1‑year outcomes of PDA transcatheter closure performed with different devices throughout a 25‑year time period in a single center. All 1036 patients who underwent transcatheter PDA closure between 1993 and 2020 were included in retrospective analysis. Various devices were used the Rashkind device (RD; n = 25), coils
Мне нравится
Комментарий
Перепост
